Tumor T<inf>1</inf> relaxation time for assessing response to bevacizumab anti-angiogenic therapy in a mouse ovarian cancer model
Tumor T<inf>1</inf> relaxation time for assessing response to bevacizumab anti-angiogenic therapy in a mouse ovarian cancer model. PLoS One. 10.